CN Patent

CN103550136B — 吸收增强的经粘膜递送装置

Assigned to Biodelivery Sciences International Inc · Expires 2016-04-13 · 10y expired

What this patent protects

本发明提供了提高受试者经粘膜吸收如芬太尼或丁丙诺啡的药物的方法和相关装置。该方法包括向受试者施用含有药物的经粘膜药物递送装置。本发明也提供了适于向受试者经粘膜施用药物的装置，及其施用方法和用途。该装置包含配置在粘膜粘附聚合物扩散环境中的药物和屏障环境。

USPTO Abstract

本发明提供了提高受试者经粘膜吸收如芬太尼或丁丙诺啡的药物的方法和相关装置。该方法包括向受试者施用含有药物的经粘膜药物递送装置。本发明也提供了适于向受试者经粘膜施用药物的装置，及其施用方法和用途。该装置包含配置在粘膜粘附聚合物扩散环境中的药物和屏障环境。

Drugs covered by this patent

Patent Metadata

Patent number
CN103550136B
Jurisdiction
CN
Classification
—
Expires
2016-04-13
Drug substance claim
No
Drug product claim
No
Assignee
Biodelivery Sciences International Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.